Red tape, reimbursements hurt pharmacists' scope of practice

Regulatory obstacles create a broad gap between pharmacists' legal scope of practice and the knowledge and training at their disposal, according to Business Insider, potentially hurting patient outcomes. For example, pharmacological graduates usually have doctoral level training and are versed in preventive care, wellness and chronic disease management. They're also often more accessible to patients than primary care providers. Despite this, fewer than half of states allow pharmacists to extensively interact with patients, take their medical histories or order certain laboratory tests. Even beyond scope of practice, Medicare reimburses pharmacists based on how many prescriptions they fill, disincentivizing them from providing more in-depth treatment. Article

Suggested Articles

Telehealth company Amwell saw its stock spike 42% in its first day of trading Thursday after raising an outsized initial public offering.

A new report outlines major telehealth policy recommendations but one physician group says the changes don't go far enough to support doctors.

Two technology companies are working on rapid COVID-19 antigen tests that can be performed by people at home without involving a laboratory.